MedTrace Logo

Study of the Modification of the Pharmacokinetic Profile of Levodopa by the Fiber Plantago Ovata Husk

NCT00507715 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2007-07-26

No results posted yet for this study

Summary

The purpose of this trial is to study the effect of the association levodopa/carbidopa with plantago ovata husk in Parkinson´s disease patients of recent diagnostic, that are being treated with levodopa/carbidopa.

Conditions

  • Parkinson's Disease, Idiopathic

Interventions

DRUG

Plantago ovata husk

5 g of effervescent powder (3.5 g pf plantago ovata husk) t.i.d. during 14 days

OTHER

hemicellulose crystalline

5g effervescent powder t.id. during 14 days

Sponsors & Collaborators

  • Rottapharm Spain

    lead INDUSTRY

Principal Investigators

  • Sierra Matilde, Ph, phD · Departamento de Ciencias Biomédicas de la Facultad de Veterinaria de la Universidad de León, León (Spain)

  • Carriedo Demetrio, MD · Hospital de León, León (Spain)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
60 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Completion
2006-11-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00507715 on ClinicalTrials.gov